Market Size and Growth Outlook
The Point of Care (POC) Diagnostics Market was valued at USD 17.13 Billion in 2024 and is expected to surpass USD 32.05 Billion by 2035. The market reached USD 18.13 Billion in 2025 and is anticipated to expand at a CAGR of 5.86% during the forecast period from 2025 to 2035.
Key Report Highlights
Point of Care (POC) diagnostics involve performing medical tests close to the patient, enabling faster clinical decisions without depending on centralized laboratory. The market includes portable diagnostic devices, rapid test kits, handheld analysers, molecular testing systems, biosensors and connected healthcare platforms used across hospitals, clinics, pharmacies, ambulatory centers and home care settings for applications such as infectious disease detection, chronic disease monitoring, cardiac testing and pregnancy testing. The near patient testing market is expanding due to rising demand for rapid diagnostic services and the growing shift towards decentralized healthcare. Increasing cases of chronic and infectious diseases, along with increasing adoption of digitally connected diagnostic systems and electronic health record integration are encouraging healthcare providers in both developed and emerging economies to implement near patient testing solutions. AI improves PoC diagnostics by processing clinical datasets, biomark patterns and patient history with high accuracy. It helps in identifying abnormal results, detecting early disease indicators and reducing manual errors through machine learning algorithms.
The rising global prevalence of infectious and chronic diseases is significantly increasing the demand for rapid near patient testing. Early diagnosis and continuous monitoring support better treatment planning, while PoC diagnostic solution provide quick results in clinics, emergency rooms and community healthcare settings without relying on centralized laboratories. Common tests include antigen, glucose, cardiac marker and molecular diagnostic tests. The growing preference for home based diagnostic testing is driving demand for convenient self-testing kits, as consumers seek to minimalize hospital visits. This has led to increased adoption of home use glucose monitors and infectious disease self help kits, along with compact, user-friendly devices equipped with digital connectivity for remote physician monitoring.
By product, the glucose monitoring was responsible for the highest share in 2024 with 31.05% share due to high diabetes cases, while cancer/ tumour market testing is expected to grow with the fastest CAGR, driven by rising cancer cases and advancements in early detection technologies. Based on end user, diagnostic centers dominated in 2024 due to high test volumes and skilled professionals while Home care is expected to grow the fastest supported by rising demands for self-testing kits, preventive healthcare awareness and digital connectivity for remote monitoring.
North America held the largest share in 2024 at 35.75% valued at USD 6.12 Billion and is projected to reach USD 11.46 Billion by 2035 with the US dominating with 83.5% share due to high chronic disease prevalence while Canada’s expanding community healthcare facilities are supporting decentralized testing adoption. Asia pacific is expected to register the fastest growth driven by strengthen primary healthcare in China, expansion of infectious diseases in India and adoption of portable molecular platforms in Japan and South Korea. Europe’s growth is supported by aging population and well-established healthcare systems in countries like the UK, Germany and France. Routine chronic disease monitoring and structured public healthcare programs are driving steady adoption of point of care diagnostics. Growth in Latin America is fuelled by expanding primary care services and infectious disease surveillance in Brazil and Mexico. Middle East and Africa are witnessing rising adoption due to healthcare infrastructure development, screening programs and improved diagnostic access in countries like the UAE and Saudi Arabia.
Point of Care (POC) Diagnostics Market Trends
- Rising burden of infectious and chronic diseases is increasing the need for fast and accurate point of care testing, specially for conditions like diabetes, cardiovascular disorders and respiratory infections that require continuous monitoring and quick diagnosis.
- Shift towards decentralized healthcare systems is driving adoption of near patient testing in clinics, emergency rooms, pharmacies and community healthcare centers, reducing dependence on centralized laboratory infrastructure.
- Integration of AI and digital connectivity is improving, accuracy, data analysis and remote monitoring.
- Increasing focus on early disease detection, especially for cancer and cardiovascular diseases is driving innovation in biomarker based and tumour marker testing to support timely diagnosis and personalised treatment.
- Strong growth in emerging markets is driven by healthcare infrastructure development and public health screening programs.
List Of Key Players in Point of Care (POC) Diagnostics Market:
- Abbott Laboratories – US
- Hoffmann-La Roche Ltd – Switzerland
- Siemens Healthineers AG – Germany
- Danaher Corporation – US
- Becton, Dickinson and Company – US
- bioMérieux SA – France
- QuidelOrtho Corporation – US
- Sekisui Diagnostics – US
- Trinity Biotech plc – Ireland
- Nova Biomedical – US
Point of Care (POC) Diagnostics Market Segmentation
The point of care diagnostics market can be segmented on the basis of product and end user:
Point of Care (POC) Diagnostics Market Product Outlook, Revenue (USD Billion) (2025-2035)
- Glucose Monitoring
- Cardiometabolic Monitoring
- Infectious Disease Testing
- Coagulation Monitoring
- Pregnancy And Fertility Testing
- Tumour/Cancer Marker Testing
- Urinalysis Testing
- Cholesterol Testing
- Drugs-Of-Abuse Testing
- Thyroid Stimulating Hormone Testing
- Fecal Occult Testing
- Other Products
Point of Care (POC) Diagnostics Market End User Outlook, Revenue (USD Billion) (2025-2035)
- Diagnostic Centers
- Home Care
- Research Laboratories
- Others
Point of Care (POC) Diagnostics Market Regional Outlook, Revenue (USD Billion) (2025-2035)
- North America
- Canada
- Mexico
- U.S.
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Europe
- Germany
- France
- UK
- Spain
- Russia
- Italy
- BENELUX
- Latin America
- Argentina
- Brazil
- Chile
- Middle East and Africa
- GCC
- Turkey
- South Africa